Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSPO | P30536 | 2/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10040773 | 1.00 | KDM4E (0.35) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL10040779 | 0.99 | KDM4E (0.36) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL10040776 | 0.97 | TSPO (0.36) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL10040777 | 0.97 | TSPO (0.33) | KDM4EATML3MBTL1TSPO | |
| SCHEMBL16557326 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL15179826 | 0.96 | KDM4E (0.37) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL15179906 | 0.96 | KDM4E (0.37) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL13805425 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL13803705 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1TSPOPTGER4 | |
| SCHEMBL9916430 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1TSPOPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9478753-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display device including the light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-10-25 | — | — | US | disclosed |
| US-9478753-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display device including the light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-10-25 | — | — | US | disclosed |
| US-20140070199-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | JUNG SUNG-HYUN (KR) | 2014-03-13 | — | — | US | disclosed |
| US-20140070199-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | JUNG SUNG-HYUN (KR) | 2014-03-13 | — | — | US | disclosed |
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-02-23 | — | — | US | disclosed |
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | AOX1, OR10J3, OCIAD1 | KDM4E 2976/4885ATM 3554/4885L3MBTL1 1452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.